An obese (body mass index, 55 kg/m²) 57-year-old female with Crohn disease had undergone a bowel resection due to sigmoid perforation in 1997, after which a transverse end colostomy was placed. She recently presented to the authors’ facility with an incarcerated parastomal hernia (Figure 1) with peritonitis (C-reactive protein [CRP]: 395 mg/L [normal: < 3.0 mg/L]; procalcitonin [PCT]: 0.96 ng/mL [normal: < 0.1 ng/mL]). During the emergency laparotomy, the incarceration with peritonitis was confirmed, and the hernia was repositioned into the intraabdominal cavity. No bowel resection was necessary. In the acute situation, an absorbable polyglycolic acid mesh (Safil, B Braun) was inserted in intraperitoneal on lay position as temporary hernia closure, traditional continuous NPWT with -125 mm Hg was applied, and the patient was stabilized with antibiotics and intensive care for 3 days, until the hernia was repaired using a 25 cm x 40 cm bovine dermal matrix mesh (Surgimend 3, 0 mm, Integra) in the intraperitoneal onlay and bridging position. The ostomy had to be placed in the midline through the mesh due to the retracted Crohn mesenterium (this also explained why stoma care had been difficult). The wound became increasingly dehiscent due to the constant stool contamination, and a progressive wound infection occurred. With regular debridement and NPWT, the wound was decontaminated over several weeks and increasingly brought to granulation; 8 weeks after the initial intervention, the wound was closed by cutaneous flap plasty.
Due to an occult intraoperative injury to the small bowel, the patient developed 2 intestinal fistulas. The subsequent wound infection with necrosis of the mobilized tissue flaps caused a ventral soft tissue defect measuring 60 cm x 50 cm (Figure 2). In addition, the patient developed life-threatening sepsis, necessitating systemic antibiotic and antifungal therapy which consisted of ciprofloxacin, linezolid, meropenem, and caspofungin according to the microbial findings until the systemic infection subsided. In the initial debridement, all of the necrotic and infected tissue was resected (Figure 3). Trying to close one of the fistulas using sutures failed during the further treatment period of several days. After initial debridement, negative pressure was applied as follows; the fistulas were isolated using SFDs. Initially, the dressings were changed in the OR; a stable change interval of 3 to 4 days was achieved from the beginning. After 6 dressing changes, the wound appeared macroscopic cleaner and the patient's clinical condition improved progressively. The systemic inflammatory parameters such as CRP, leukocytes, and PCT showed a significant decrease. The wound showed a continuously thickening layer of granulation tissue. Therefore, the NPWTi-d therapy was able to be changed to a conventional NPWT therapy combined with SFDs (Figure 4A). After 8 additional dressing changes on demand (between 2–4 days) over 3 additional weeks, the OR was no longer required for dressing changes and they could be performed bedside. However, as wound area decreased and the wound became more superficial, obtaining a dressing seal became more difficult, increasing dressing change frequency. In addition, it was not possible to achieve the desired split-skin coverage due to the lack of donor sites, so secondary healing continued. Eight months after the initial operation, the patient was discharged to a nursing home with a small granulated wound surrounding the fistulas (Figure 4B) but free of systemic infection.
Dressing application technique
When first implemented, the dressing application technique had 3 objectives: (1) wound decontamination, (2) granulation tissue generation, including on the bovine mesh, and (3) acid succus isolation. For this purpose, the SFDs (WOUND CROWN; 3M + KCI) were sealed with cohesive skin protection plates (Eakin) on the wound side and fixed with a hydrophobic polyurethane ether foam (V.A.C. GRANUFOAM Dressings; 3M + KCI) in the center of the fistula-bearing wound section. The upper fistula was located distal to its counterpart and produced almost no effluent and was covered with a skin protection plate to avoid contact with the NPWT foams in the early treatment phase. The peripheral wound sections and wound pockets were filled with a hydrophilic polyurethane ether foam dressing (V.A.C. VERAFLO Dressing; 3M + KCI). An instillation pad was attached to the right and left lateral to the hydrophobic polyurethane ether foam dressing. The negative pressure connectors were placed far into the flanks (Figure 5).
This arrangement of the dressings, the instillation, and negative pressure connections made it possible to generate a directed fluid flow from medial to lateral during the instillation phases; the fistula adapters were largely excluded from the instillation field by the more hydrophobic foam without losing their tightness.
For this patient, NPWTi-d settings were as follows:
• Instillation volume: This was determined using the fill assist after every dressing change (fill assist stopped when fluid could be detected in the flanks; instillation volume varied from 800 mL in the beginning (2 instillation devices placed serial) to 250 mL at the end of instillation therapy).
• Solution and soak time: An isotonic (0.9 %) saline solution was set to dwell for 10 minutes.
• Negative pressure wound therapy target setting: NPWT device was set at -125 mm Hg and left in place for 2 to 4 hours, depending on the macroscopic aspect (ie, clean = 4 hours, contaminated = 2 hours). Intensity was set to low.
Regular instillation with saline helped achieve rapid macroscopic cleansing and wound granulation even at the first dressing change 2 days after initial debridement. Although microbiological examinations revealed constant wound contamination, no significant systemic infections occurred while providing NPWTi-d and subsequent NPWT over almost 120 days.